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Results: DNA methylation levels of the CpG sites adjacent to transcription start site
tended to be low (CpG1: 51.32%, CpG2: 53.24%, CpG3: 40.71%, CpG4: 24.41%,
CpG5: 13.80%, CpG6: 10.00%, CpG7: 15.53%, CpG8: 6.04%, CpG9: 15.12%). For
each CpG site and the average value of 9 CpG sites, methylation levels were lower
(except for CpG2) in other three groups, compared with nondepression-non-
hypertension group, but not statistically signiﬁcant. Multiple regression analysis
indicated no signiﬁcant differences among different groups after controlling for age
and BMI. Spearman’s correlation coefﬁcients and PCA found that CpG5-9 and CpG4
are highly representable by the ﬁrst principle component, while CpG2 had a big
loading on the second principle component and CpG1, CpG3 land in between. HCA
showed that all observations may be clustered into three subgroups, in which the
samples from all hypertension and depression combinations were mixed. Therefore,
using the methylated levels on these 9 CpG sites, we cannot discriminate these four
groups apart.
Conclusions: The present study ﬁrstly detects the role of epigenetics on the
depression-hypertension association and ﬁnds that there are no signiﬁcant differences
in DNA methylation levels in NET gene among groups. Further studies should take
into consideration the role of methylation in other CpG sites and other potential
epigenetic mechanisms in the regulation of NET gene on the association between
depression and hypertension. Furthermore, studies with prospective design or studies
conducted in cell lines or animal models with interventions are needed for mechanism
research.
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Objectives: While mental health problem, such as depressions often co-occur with
heart disease, less is known about the prevalence and really clinical diagnosis or
treatment status of anxiety or depression in patients with atherosclerotic cardiovas-
cular disease(ASCVD). The aim of the study was to investigate the prevalence and the
real world status of diagnosis and treatment of anxiety /depression disorders in those
with ASCVD who admitted at department of cardiology. This is useful to lay the
foundation for a better management of patients with the comorbidity of mental
disorders and heart disease.
Methods: 292 men and 158 women from inpatients of department of cardiology
between October 2013 and February 2014 were assessed for ASCVD. Anxiety and
depressive symptoms were measured using face-to-face interviews with the Hospital
Anxiety and Depression Scale (HADS) during the period of hospitalization. The initial
medical history about the diagnosis and treatments of anxiety or /and depression were
looked up.
Results: (1) Out of 450 patients, 204 (45.3%) patients were diagnosed with anxiety
or/and depression. The most prevalent psychological disorder was only anxiety
(112 cases, 24.9%), followed by only depression (50 cases, 11.1%), and comor-
bidity of anxiety and depression (42 cases, 9.3%). The mean HAD-A score for 154
patients with anxiety was 17.356.21, and the mean HAD-D score for 92 patients
with depression was 24.457.16. Multivariables logistic regression analysis
indicated that factors, such as sex (female)[OR¼1.63, 95% CI 1.21-2.21,
P¼0.002], age (40-60 year old) [OR¼1.54, 95% CI 1.15-2.07, P¼0.004], poor
sleep quality [OR¼1.62, 95% CI, 1.34-1.96, P¼0.0001] were signiﬁcantly asso-
ciated with incidence of anxiety or /and depression respectively. (2) Out of 204
ASCVD patients with anxiety or /and depression, only 25 cases (12.6%) were
diagnosed with anxiety or /and depression , and only 23 (11.3%)cases were treated
with anti-anxiety or depression drugs at initial medical history. The most frequent
drug was vitamin (10 cases, 43.4%), then Traditional Chinese Medicine(6 cases,
26.0%), benzodiazepines (4 cases, 17.3%), ﬂupentixol and melitracen(2 cases,
8.6%), and mirtazapine(1 case, 4.3%). (3) Twenty-two physicians who majored
cardiology conducted questionnaire investigation about diagnostic standard and
treatment of anxiety or depression disorders. The correct answer rates for 10
(45.4%) physicians were lower than 60%, 8 physicians between 60-80%, and 4
physicians higher than 80%. Only 2 physicians presented 100% of correct
answers.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CConclusions: Anxiety / depression disorders is common in those with ASCVD.
ASCVD Patients with female, middle-aged (40-60years), or those with sleep disorder
were at increased risk for elevated anxiety and depressive symptoms. In clinical
practice, the anxiety /depression disorders in patients with ASCVD were under-
detected and under-treated. It is pivotal to train physicians of cardiology and elevate
their abilities of screening and management of Mental - physical co-morbidity.
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Objectives: Blood transfusion has several risks including allergic reaction, acute
hemolysis, infectious disease and so on. Both physicians and patients are always
cautious to decide on blood transfusion. The purpose of this study was to explore
whether there are gender difference in anxiety for the ﬁrst blood transfusion in patients
with different diseases.
Methods: 315 patients (153 men and 162 women )were enrolled in this prospective,
comparative study and median age was 38 yeanrs(range 17-72). The disease consisted
of 85 chronic hepatitis B, 73 leukemia, 69 gastric ulcer, 48 chronic renal failure and 40
gynecological oncology. Various blood products including plasma, red blood cells
suspension and platelet were infused. Anxiety was evaluated by patients’ clinical
symptoms during the ﬁrst blood transfusion.
Results: For the paitents with same disease, women had higher anxiety levels
than men during the ﬁrst blood transfusion [(0.83 0.60) vs (0.55  0.70),
P<0.05].
Conclusions: Women were more anxious than men during the ﬁrst blood transfusion
and this relationship is independent of age, race, education level and kinds of blood
product.Cardiac Cath Lab Technology
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Objectives: To determine the variation of aortic regional pressure at different pacing
rates in right ventricale.
Methods: A group of 10 healthy adult goats were selected for the study. Under
general anesthesia, pacing rate was increased from 150 to 350 beats/min with incre-
ment of 25 beats/min. Systolic, diastolic and mean aortic pressure were determined at
different pacing rate with an external pacemaker. Then the pressure gradients were
ﬁgured out.
Results: The systolic supravalvular aortic pressure and systolic transvalvular aortic
pressure gradient curve was decreased with the pacing rate increase. The diastolic
transvalvular aortic pressure gradient curve was elevated with the pacing rate increase.
However, the diastolic supravalvular aortic pressure curve was similar to an irregular
parabolic curve.
Conclusions: Pacing in right ventricular apical results in decline in aortic pressure.
And for goats, the appropriate pacing frequency that reducing the transvalvular
pressure gradient effectively with less danger was 250-300 beats/min.ardiovascular-Disciplinary Research C223
